In this regard, the impact of other synthetic or biological DMARDs, such as sulfasalazine and TNF-α blockers, on IL-22 production and frequencies of IL-22+Th cells in RA remains to be investigated. This evidence concerns the gene TNF and rheumatoid arthritis.